MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT
description
Transcript of MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT
![Page 1: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/1.jpg)
MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs):
FINDINGS FROM THE 2012 G-FINDER REPORT
![Page 2: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/2.jpg)
Policy Cures
Innovative ideas and accurate analysis to accelerate development and uptake of new drugs, vaccines, diagnostics and other products for neglected diseases of the developing world
![Page 3: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/3.jpg)
• Annual survey of global investment into R&D of new neglected disease products
• Neutral, comparable, comprehensive analysis
• Commissioned by the Bill & Melinda Gates Foundation
• 31 neglected diseases• 134 product areas• All R&D stages
G-FINDER
![Page 4: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/4.jpg)
$84.9m higher in 2011 than in 2007
Malaria – overall funding
![Page 5: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/5.jpg)
Malaria – by product area
• Vaccines, diagnostics and vector control R&D ↑
• Drug R&D →
• Basic research ↑
![Page 6: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/6.jpg)
Who funds malaria R&D?
Gates Foundation 26.3%
US NIH 20.7%
Industry (aggregate) 18.7%
66%
![Page 7: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/7.jpg)
NTDs
50% 65%
Buruli ulcerDengueKinetoplastids (Chagas, HAT, leishmaniasis)
Helminths (lymphatic filariasis, STHs, cysticercosis, onchocerciasis, schistosomiasis)
LeprosyTrachoma
HIV/AIDS
Malaria
TB
Diarrhoeal diseases
Bacterial pneumonia & meningitis
Salmonella infections
Rheumatic fever
Guinea worm disease
Echinococcosis
Foodborne trematode infections
Rabies
Yaws
WHO classification G-FINDER
![Page 8: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/8.jpg)
NTDs – dengue, kinetoplastids and helminths
![Page 9: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/9.jpg)
NTDs – leprosy, Buruli ulcer and trachoma
$7.4m$5.8m $9.6m
![Page 10: MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT](https://reader036.fdocuments.in/reader036/viewer/2022062520/568164d8550346895dd71bd1/html5/thumbnails/10.jpg)
Download the full report atwww.policycures.org/g-finder2012.html